Gene therapy facility
bluebird bio is a clinical-stage biotech company that develops gene therapies for severe genetic and rare diseases.
About bluebird bio
bluebird bio is a clinical-stage company that develops potentially transformative therapies with product platforms including gene therapy, cancer immunotherapy and gene editing.
PM Group has worked with bluebird bio for several years, providing high level Subject Matter Expert (SME) support, as well as engineering design services.
Related Specialist
Viral vector manufacturing facility
PM Group designed a 53,000 sq.ft. world-class viral vector manufacturing facility in Durham, NC. The project had a fast track schedule with 16 months from construction commencement to manufacturing start.
Our team provided process engineering design including P&IDs, equipment specification, procurement support, process simulation and modeling for production planning.
Key stat 1
1st
Gene therapy facility in the USA
Key stat 2
53,000
sq.ft. world-class viral vector manufacturing facility
Key stat 3
16 mth
from construction start to manufacturing start-up
Technologies on this project include:
- Single use technologies (bioreactors and purification) for viral vector preparation
- Filling line and isolator
- BSL-2 level of containment
Contact Us
Thank you, we’ll be in touch shortly.
In the meantime you may find this content relevant to your interests. Talk soon.
